Loading...
XSTO
SCIB
Market cap13mUSD
Jun 05, Last price  
0.39SEK
1D
0.78%
1Q
4.86%
Jan 2017
-97.93%
IPO
-99.20%
Name

SciBase Holding AB (publ)

Chart & Performance

D1W1MN
P/E
—
P/S
4.42
EPS
—
Div Yield, %
—
Shrs. gr., 5y
44.93%
Rev. gr., 5y
26.21%
Revenues
30m
+27.79%
097,0001,600,0004,151,0006,436,0006,859,0006,899,0009,276,0009,521,00011,727,00017,890,00023,245,00029,705,000
Net income
-61m
L+9.97%
-40,964,393-79,502,000-38,755,000-41,532,000-53,086,000-42,464,000-44,215,000-39,539,000-34,989,000-41,690,000-39,899,000-55,585,000-61,125,000
CFO
-57m
L+10.39%
-36,437,540-34,026,000-37,077,000-46,588,000-47,850,000-44,180,000-37,482,000-37,956,000-33,861,000-39,501,000-44,466,000-51,984,000-57,383,000
Earnings
Aug 19, 2025

Profile

SciBase Holding AB (publ), a medical technology company, develops and sells instruments for the detection of skin cancer and other skin conditions in Europe and internationally. Its product includes Nevisense and Nevisense Go, a point of care platform that addresses in the areas of melanoma detection, non-melanoma skin cancer detection, and skin barrier assessment. The company has a collaboration agreement with Advanced Dermatology and Cosmetic Surgery (ADCS) group. SciBase Holding AB (publ) was founded in 1998 and is headquartered in Sundbyberg, Sweden.
URL
https://www.scibase.com
IPO date
Jun 02, 2015
Employees
22
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
29,705
27.79%
23,245
29.93%
17,890
52.55%
Cost of revenue
96,668
77,116
64,277
Unusual Expense (Income)
NOPBT
(66,963)
(53,871)
(46,387)
NOPBT Margin
Operating Taxes
(3,275)
Tax Rate
NOPAT
(66,963)
(53,871)
(43,112)
Net income
(61,125)
9.97%
(55,585)
39.31%
(39,899)
-4.30%
Dividends
Dividend yield
Proceeds from repurchase of equity
41,877
79,602
BB yield
-57.38%
-88.39%
Debt
Debt current
2,618
2,910
Long-term debt
10,976
13,334
Deferred revenue
Other long-term liabilities
1,570
(1,000)
Net debt
(11,245)
(20,527)
(2,588)
Cash flow
Cash from operating activities
(57,383)
(51,984)
(44,466)
CAPEX
(428)
(383)
(381)
Cash from investing activities
(428)
(383)
(381)
Cash from financing activities
34,910
67,681
(2,479)
FCF
(78,447)
(54,835)
(49,587)
Balance
Cash
11,245
34,121
18,832
Long term investments
Excess cash
9,760
32,959
17,938
Stockholders' equity
(723,452)
(662,380)
(611,762)
Invested Capital
761,672
712,233
644,666
ROIC
ROCE
EV
Common stock shares outstanding
177,994
107,980
70,546
Price
0.41
-50.84%
0.83
-78.17%
3.82
-30.80%
Market cap
72,978
-18.96%
90,055
-66.58%
269,487
-24.47%
EV
61,733
69,528
267,627
EBITDA
(66,963)
(50,483)
(42,736)
EV/EBITDA
Interest
298
367
5
Interest/NOPBT